Celexa (citalopram) has been linked to an increased risk of birth defects, especially heart defects, when women use it during pregnancy.
What is the problem?
Celexa (citalopram) is an antidepressant in a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is Pregnancy Category C, which means it could potentially cause birth defects, but can still be used if the benefits outweigh the risks.
Several studies have linked Celexa to an increased risk of birth defects. In 2011, the British Medical Journal published a study linking Celexa to a 2.5-fold increased risk of septal heart defects (also known as “hole in the heart” defects). The FDA has also published a Safety Communication about the risk of Persistent Pulmonary Hypertension of the Newborn (PPHN).
Celexa Class Action Lawsuit Information
March 14, 2014 — Law360 reports that Forest Laboratories, Inc., the manufacturer of Celexa, has agreed to resolve a multi-district litigation (MDL) for between $7.7 million and $10.4 million. The lawsuit accused Forest of misleading Missouri parents into buying Celexa for children although it was only approved for adults.